Target intelligence / Profile preview

Ankyrin repeat domain 20 family member A19, pseudogene (ANKRD20A19P)

Target
ANKRD20A19P
Molecular classification
Pseudogene, Non-coding RNA (potential; inferred from general pseudogene function)
01

Overview

Ankyrin repeat domain 20 family member A19, pseudogene (abbreviated ANKRD20A19P) is a human pseudogene located under NCBI Gene ID 400110[5][6]. As a pseudogene, it is considered a non-functional genomic DNA sequence originally derived from a functional gene but now believed to lack the potential to encode a functional protein due to disabling mutations[2][4]. While pseudogenes were historically labeled as "junk" DNA, recent research indicates that some can have regulatory roles at the RNA level, such as by acting as microRNA decoys or sources of regulatory small RNAs[2]. However, as of the most recent sources, there are no established protein-coding, regulatory, or disease-related functions reported specifically for ANKRD20A19P. Key points: - This gene is classified as a pseudogene, not an active receptor, enzyme, or recognized therapeutic target[5][6]. - There are currently no known interacting drugs, actionable biomarkers, clinical safety concerns, or well-defined mechanisms of action for this pseudogene. - ANKRD20A19P should not be considered a therapeutic target based on current knowledge[5][6]. - No commonly used alternative names or aliases were detected in the sources. If you require structured data or database identifiers (e.g., HGNC, Entrez, Ensembl), those can be provided separately.

02

Biological functions

Other (general pseudogene regulatory/noncoding RNA roles possible but no specific function recorded for this gene)
03

Disease associations

Other (no specific disease association reported for this pseudogene; some pseudogenes play regulatory roles in diseases, but this is not established for ANKRD20A19P)

Beyond the preview

Go deeper on Ankyrin repeat domain 20 family member A19, pseudogene (ANKRD20A19P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 20 family member A19, pseudogene (ANKRD20A19P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call